236 related articles for article (PubMed ID: 38264574)
1. Infections After Liver Transplant -Timeline, Management and Prevention.
Shinde AS; Kapoor D
J Clin Exp Hepatol; 2024; 14(3):101316. PubMed ID: 38264574
[TBL] [Abstract][Full Text] [Related]
2. High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction.
Chen F; Pang XY; Shen C; Han LZ; Deng YX; Chen XS; Zhang JJ; Xia Q; Qian YB
World J Gastroenterol; 2020 Dec; 26(45):7191-7203. PubMed ID: 33362376
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival.
Azhie A; Sheth P; Hammad A; Woo M; Bhat M
Liver Transpl; 2021 Oct; 27(10):1468-1478. PubMed ID: 34165872
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of liver transplant recipients.
Thuluvath PJ
J Clin Exp Hepatol; 2011 Dec; 1(3):199-203. PubMed ID: 25755386
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
Krisl A; Stampf S; Hauri D; Binet I; Mueller T; Sidler D; Hadaya K; Golshayan D; Pascual M; Koller M; Dickenmann M; The Swiss Transplant Cohort Study Stcs
Swiss Med Wkly; 2020 Nov; 150():w20354. PubMed ID: 33277913
[TBL] [Abstract][Full Text] [Related]
6. Steroid-sparing maintenance immunosuppression is safe and effective after simultaneous liver-kidney transplantation.
Weeks SR; Luo X; Toman L; Gurakar AO; Naqvi FF; Alqahtani SA; Philosophe B; Cameron AM; Desai NM; Ottmann SE; Segev DL; Garonzik-Wang J
Clin Transplant; 2020 Oct; 34(10):e14036. PubMed ID: 32652700
[TBL] [Abstract][Full Text] [Related]
7. Current Practice in Immunosuppression in Pediatric Liver Transplantation.
Vincenzi R; Fonseca EA; Roda KMO; Chapchap P; Neto JS
Curr Pharm Des; 2020; 26(28):3402-3405. PubMed ID: 32534559
[TBL] [Abstract][Full Text] [Related]
8. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary complications in patients receiving a solid-organ transplant.
De Gasperi A; Feltracco P; Ceravola E; Mazza E
Curr Opin Crit Care; 2014 Aug; 20(4):411-9. PubMed ID: 24979712
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
[TBL] [Abstract][Full Text] [Related]
11. From immunosuppression to tolerance.
Adams DH; Sanchez-Fueyo A; Samuel D
J Hepatol; 2015 Apr; 62(1 Suppl):S170-85. PubMed ID: 25920086
[TBL] [Abstract][Full Text] [Related]
12. Post liver transplant recurrent and de novo viral infections.
Jothimani D; Venugopal R; Vij M; Rela M
Best Pract Res Clin Gastroenterol; 2020; 46-47():101689. PubMed ID: 33158469
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin perioperative prophylaxis for the prevention of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
Sarwar S; Koff A; Malinis M; Azar MM
Transpl Infect Dis; 2020 Jun; 22(3):e13280. PubMed ID: 32216015
[TBL] [Abstract][Full Text] [Related]
14. Post-liver transplantation medical complications.
Moreno R; Berenguer M
Ann Hepatol; 2006; 5(2):77-85. PubMed ID: 16807513
[TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
[TBL] [Abstract][Full Text] [Related]
16. Management of opportunistic infections in solid-organ transplantation.
Chiu LM; Domagala BM; Park JM
Prog Transplant; 2004 Jun; 14(2):114-29. PubMed ID: 15264456
[TBL] [Abstract][Full Text] [Related]
17. Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.
Wang P; Jiang Z; Wang C; Liu X; Li H; Xu D; Zhong L
Front Immunol; 2020; 11():1723. PubMed ID: 33013824
[TBL] [Abstract][Full Text] [Related]
18. Evolving challenges with long-term care of liver transplant recipients.
Odenwald MA; Roth HF; Reticker A; Segovia M; Pillai A
Clin Transplant; 2023 Oct; 37(10):e15085. PubMed ID: 37545440
[TBL] [Abstract][Full Text] [Related]
19. Infections in liver transplant recipients.
Romero FA; Razonable RR
World J Hepatol; 2011 Apr; 3(4):83-92. PubMed ID: 21603030
[TBL] [Abstract][Full Text] [Related]
20. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
